In our study, plasma MMP-2 concentrations were slightly higher in patients with benign lesions (BL) compared to OC patients, but this was not a statistically significant difference (BL—median: 211 ng/mL; OC—median: 203 ng/mL). The gene discussed is MMP2; the disease is neoplasm.